Characterization of in vitro inhibition of human immunodeficiency virus by purified recombinant CD4.
The first step in infection of human T cells with human immunodeficiency virus (HIV) is binding of viral envelope glycoprotein gp120 to its cellular receptor, CD4. The specificity of this interaction has led to the development of soluble recombinant CD4 (rCD4) as a potential antiviral and therapeuti...
保存先:
| 出版年: | J Virol |
|---|---|
| 主要な著者: | , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
American Society for Microbiology (ASM)
1989
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC251054/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/2550671/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/jvi.63.10.4370-4375.1989 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|